Login
Toggle navigation
Videos
Categories
Trending
Innovations at K.EY 2023 as Told by Davide Tinazzi | Davide Tinazzi - CEO of Energy SpA
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Davide Tinazzi is Chief Executive Officer at Energy SpA.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:00:00
C4X Discovery Holdings PLC on expanding its portfolio - Clive Dix BSc PhD HonFBPhS, Interim Executive Chairman & CEO, C4X Discovery Holding
00:10:00
Eastmain Resources Highlights High-Grade Gold Projects in Quebec at One-to-One London.
00:10:00
Revisiting the Landscape: Macerich CEO Disputes Notion of A-Quality Regional Mall Decline
00:10:00
Basic Game Theory Teaches Us About Startups|Michael Seibel,Managing Director, Early Stage and Group Partner,Y Combinator
00:10:00
Unlock Financial Freedom with the Infinite Banking Concept
00:10:00
Presentation by Kay Quinoa, CEO of Tier Two Minerals Limited
00:10:00
The Evolving Relationship Between Mining and Energy Sectors Towards Carbon Footprint Reduction and Technological Advancements | Fabrizio Barderi, CEO, Enel Distribucion Chile SA.
00:00:00
Tomas Kirchhausen, Ph.D. , Springer Family Professor of Pediatrics (HMS) | Exploring Cells with 3D Light Microscopy
00:10:00
Reasons for Being Christian: Insights from Professor Thomas Ward|Thomas Ward,Professor,Baylor University
00:10:00
Necessary Trouble: Drew Faust on Growing Up and Making Impact
00:10:00
Exploration and Mining Industry Discussions and Updates
00:10:00
Canada's Minerals and Metals Plan: Driving Competitiveness and Sustainability | Ric Gros - CEO of Canadian Minerals and Metals Plan